Osteogenic protein-1 induced bone formation in an infected segmental defect in the rat femur

被引:102
作者
Chen, XQ [1 ]
Kidder, LS [1 ]
Lew, WD [1 ]
机构
[1] Midwest Orthopaed Res Fdn, Minneapolis, MN 55404 USA
关键词
D O I
10.1016/S0736-0266(01)00060-2
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
The goal of this study was to use a segmental defect model in the rat femur to determine if osteogenic protein-1 (OP-1) is capable of inducing bone formation in the presence of bacterial contamination. A 6 mm segmental defect was surgically created and stabilized with a polyacetyl plate and Kirsehner wires in one femur in each of 126 Sprague Dawley rats. The animals were divided into eight groups in which the defect was either left untreated, or subjected to various combinations of OP-1 (11 or 50 mug), lyophilized bovine type I collagen (carrier for the OP-1), and 10(5) colony-forming units of Staphylococcus aureus. The animals were euthanized at either 2, 4, or 9 weeks. Quantitative radiographic and histologic analyses were performed on the harvested tissue. The initial contamination progressed to infection in all animals receiving bacteria, as determined by qualitative bacteriology. There was very little, if any, bone formation in the untreated defects, and in the contaminated defects with or without collagen carrier. Bone formation was significantly greater in contaminated defects with either dose of OP-1, compared with contaminated defects without OP-1. The 50 mug dose of OP-1 induced significantly more bone formation than the 11 mug dose, both with and without bacteria. This investigation has demonstrated that OP-1 maintains its osteoinductive capability in a contaminated segmental defect. OP-1 may potentially be used in the clinical management of contaminated fractures. (C) 2002 Orthopaedic Research Society. Published by Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:142 / 150
页数:9
相关论文
共 38 条
[1]   Local tissue properties in bone healing: Influence of size and stability of the osteotomy gap [J].
Augat, P ;
Margevicius, K ;
Simon, J ;
Wolf, S ;
Suger, G ;
Claes, L .
JOURNAL OF ORTHOPAEDIC RESEARCH, 1998, 16 (04) :475-481
[2]  
BOSTROM MPG, 1995, T ORTHOP RES SOC, V20, P229
[3]   AN INVIVO MODEL TO STUDY THE PATHOBIOLOGY OF INFECTIOUS BIOFILMS ON BIOMATERIAL SURFACES [J].
BURET, A ;
WARD, KH ;
OLSON, ME ;
COSTERTON, JW .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, 1991, 25 (07) :865-874
[4]  
COLE BJ, 1993, J BONE MINER RES, V8, pS244
[5]   EFFECT OF RECOMBINANT HUMAN OSTEOGENIC PROTEIN-1 ON HEALING OF SEGMENTAL DEFECTS IN NONHUMAN-PRIMATES [J].
COOK, SD ;
WOLFE, MW ;
SALKELD, SL ;
RUEGER, DC .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1995, 77A (05) :734-750
[6]  
Cook SD, 1999, ORTHOPEDICS, V22, P669
[7]   IN-VIVO EVALUATION OF RECOMBINANT HUMAN OSTEOGENIC PROTEIN (RHOP-1) IMPLANTS AS A BONE-GRAFT SUBSTITUTE FOR SPINAL FUSIONS [J].
COOK, SD ;
DALTON, JE ;
TAN, EH ;
WHITECLOUD, TS ;
RUEGER, DC .
SPINE, 1994, 19 (15) :1655-1663
[8]   Induction of bone by a demineralized bone matrix gel: A study in a rat femoral defect model [J].
Feighan, JE ;
Davy, D ;
Prewett, IB ;
Stevenson, S .
JOURNAL OF ORTHOPAEDIC RESEARCH, 1995, 13 (06) :881-891
[9]   Osteogenic activity of OP-1 bone morphogenetic protein (BMP-7) in a human fibular defect [J].
Geesink, RGT ;
Hoefnagels, NHM ;
Bulstra, SK .
JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME, 1999, 81B (04) :710-718
[10]   CELL BIOLOGY AND MOLECULAR MECHANISMS IN ARTIFICIAL DEVICE INFECTIONS [J].
GRISTINA, AG ;
GIRIDHAR, G ;
GABRIEL, BL ;
NAYLOR, PT ;
MYRVIK, QN .
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1993, 16 (11) :755-763